Oral Microbiome Therapy for C. difficile Infection A majo | UPDATES IN MEDICINE
Oral Microbiome Therapy for C. difficile Infection
A major challenge with the treatment of Clostridioides difficile infection is restoring the antibiotic-associated alterations of bowel flora to a state less hospitable to C. difficile. In this trial, a microbiome-replacement therapy, SER-109, was used to treat patients with recurrent C. difficile infection and was shown to reduce the risk of further recurrence.
